SCHEMBL1522567

SCHEMBL1522567

NS(=O)(=O)c1ccccc1NC(=O)c1c(O)c2cccnc2n(OCc2ccccc2)c1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.57
USP2 O75604 7/20 0.57
NPC1 O15118 4/20 0.55
RAB9A P51151 4/20 0.55
KMT2A Q03164 7/20 0.52
MEN1 O00255 6/20 0.52
HTT P42858 5/20 0.52
LMNA P02545 4/20 0.52
ALDH1A1 P00352 4/20 0.52
TSHR P16473 3/20 0.52
GAA P10253 1/20 0.52
MAPK1 P28482 1/20 0.51
UBE2N P61088 1/20 0.51
HBB P68871 1/20 0.51
HPGD P15428 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
TNF P01375 1/20 0.51
NOD2 Q9HC29 1/20 0.51
NOD1 Q9Y239 1/20 0.51
CNR1 P21554 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1522784 0.87 KDM4E (0.61) KDM4EUSP2NPC1RAB9AKMT2A
SCHEMBL3516729 0.85 HIF1A (0.50) KDM4EUSP2NPC1RAB9AKMT2A
SCHEMBL16238692 0.80 CNR2 (0.46) KDM4EUSP2KMT2AMEN1LMNA
SCHEMBL3515850 0.79 L3MBTL1 (0.54) KDM4ENPC1RAB9AKMT2AMEN1
SCHEMBL3514876 0.79 CNR2 (0.44) KDM4ENPC1RAB9AKMT2AMEN1
SCHEMBL1522959 0.76 KDM4E (0.53) KDM4EUSP2KMT2AMEN1HTT
SCHEMBL1522418 0.76 CNR2 (0.54) KDM4EUSP2NPC1RAB9AKMT2A
SCHEMBL1522633 0.76 CNR2 (0.54) KDM4EUSP2NPC1RAB9AKMT2A
SCHEMBL1522406 0.76 KDM4E (0.56) KDM4EUSP2NPC1RAB9AKMT2A
SCHEMBL15859775 0.75 EGLN1 (0.49) KDM4EHTTLMNAALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2361913-A1 Anti-infective agents Abbott Laboratories (US) 2011-08-31 EP disclosed
US-7902203-B2 Anti-infective agents ABBOTT LABORATORIES, INC. (US) 2011-03-08 US disclosed
EP-1560827-B1 ANTI-INFECTIVE AGENTS ABBOTT LAB (US) 2010-12-29 EP disclosed
US-20050075331-A1 Anti-infective agents ABBOTT LABORATORIES 2005-04-07 US disclosed
US-20040167123-A1 Anti-infective agents ABBVIE INC. 2004-08-26 US disclosed
US-20040162285-A1 Anti-infective agents ABBOTT LABORATORIES 2004-08-19 US disclosed
US-20040097492-A1 Anti-infective agents ABBOTT LABORATORIES 2004-05-20 US disclosed
US-20040087577-A1 Anti-infective agents ABBOTT LABORATORIES 2004-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097492-A1 Anti-infective agents POLR1C, RPL5, POLB KDM4E 4352/4885USP2 3734/4885NPC1 468/4885
US-20040162285-A1 Anti-infective agents POLR1C, RPL5, POLB KDM4E 4352/4885USP2 3734/4885NPC1 468/4885
US-20040167123-A1 Anti-infective agents SERPINB1, CYP51A1, ZC3HAV1 KDM4E 4075/4885USP2 3368/4885NPC1 104/4885
US-20050075331-A1 Anti-infective agents RPL35, POLI, POLRMT KDM4E 3897/4885USP2 2866/4885NPC1 174/4885
US-20040087577-A1 Anti-infective agents POLR1C, RPL5, POLB KDM4E 4352/4885USP2 3734/4885NPC1 468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.